JULÄINE Of Sweden — 2196434
Numéro de demande
2196434
Numéro d'enregistrement
TMA1293258
Numéro de l’enregistrement international
1670285
Type(s)
Dessin
Catégorie
Marque de commerce
Statut de l'OPIC
REGISTERED
Statut de TM5
ACTIF/ENREGISTREMENT/
émit et actif
La demande de marque a été enregistrée auprès de l’Office.
Produite
2022-05-20
Date d’enregistrement international
2022-05-20
Enregistrée
2025-02-24
Date d’expiration de l’enregistrement
2032-05-20
Propriétaire inscrit
Nordberg Medical AB
Hälsovägen 7
SE-141 57 HUDDINGE
SUÈDE
Agent
BORDEN LADNER GERVAIS LLP
World Exchange Plaza
100 Queen Street, Suite 1300
Ottawa
ONTARIO K1P1J9
Documents
Rubriques d'index
- JULÄINE OF SWEDEN
Produits (Classe de Nice & Énoncé(s))
- 5
- (1) Pharmaceutical substances for the treatment of damaged skin and tissue, namely, wrinkles, scars, fine lines, pores, folds, and wounds; pharmaceutical preparations for the treatment of wrinkles; anti-aging medicated skin care preparations; dermatological pharmaceutical products for use in filling out wrinkles, folds, scars, and lips, for face and body contouring, for rejuvenating the skin and for stimulation of collagen production; dermatological pharmaceutical products, namely, biostimulatory injectable dermal filler implant; dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for use in non-surgical treatment of wrinkles, fine lines, folds, and scars; dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for use in non-surgical restorative and aesthetic treatment of lips, face, and skin; dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for use in non-surgical restorative and aesthetic face and body contouring; dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for use in non-surgical skin rejuvenation; dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for stimulation of collagen production; dermatological pharmaceutical products, namely, injectable dermal implant for the treatment of wrinkles, fine lines, folds, and scars; dermatological pharmaceutical products, namely, injectable dermal implant for restorative and aesthetic treatment of lips, face, and skin; dermatological pharmaceutical products, namely, injectable dermal implant for restorative and aesthetic face and body contouring; dermatological pharmaceutical products, namely, injectable dermal implant for non-surgical skin rejuvenation; dermatological pharmaceutical products, namely injectable dermal implant for stimulation of collagen production; injectable dermal fillers; pharmaceutical preparations for skin care, namely, medicated skin care preparations for treating, reducing, and preventing lines, pores, and loss of skin firmness; pharmaceutical preparations for skin wounds, namely, adhesive bandages, antiseptic liquid bandages, liquid bandages, wound dressings, adhesive wound closures; pharmaceutical preparations for treating skin disorders, namely, wrinkles, scars, fine lines, pores, folds, and wounds; pharmaceutical preparations for the treatment of damaged skin and tissue, namely, wrinkles, scars, fine lines, pores, folds, and wounds.
- 10
- (2) Medical apparatus and devices, namely, biostimulatory injectable dermal filler implant; medical apparatus and devices, namely, injectable poly-l-lactic acid for use in non-surgical treatment of wrinkles, fine lines, folds, and scars; medical apparatus and devices, namely, injectable poly-l-lactic acid for use in non-surgical restorative and aesthetic treatment of lips, face, and skin; medical apparatus and devices, namely, injectable poly-l-lactic acid for use in non-surgical restorative and aesthetic face and body contouring; medical apparatus and devices, namely, injectable poly-l-lactic acid for use in non-surgical skin rejuvenation; medical apparatus and devices, namely, injectable poly-l-lactic acid for stimulation of collagen production; medical apparatus and devices, namely, injectable dermal implant for the treatment of wrinkles, fine lines, folds, and scars; medical apparatus and devices, namely, injectable dermal implant for restorative and aesthetic treatment of lips, face, and skin; medical apparatus and devices, namely, injectable dermal implant for restorative and aesthetic face and body contouring; medical apparatus and devices, namely, injectable dermal implant for non-surgical skin rejuvenation; medical apparatus and devices, namely, injectable dermal implant for stimulation of collagen production; hypodermic syringes for injections for medical purposes; injection needles for medical use.
Services (Classe de Nice & Énoncé(s))
- 44
- (1) Dermatological services for treating skin conditions; cosmetic body treatment services; cosmetic needling services; injectable filler treatments for cosmetic purposes; cosmetic body care services; cosmetic skin care services; providing medical information in the field of pharmaceutical preparations and medical devices for the treatment of wrinkles; providing information in the fields of dermatological health and information on dermatological issues; beauty therapy treatments, namely, cosmetic care services in the nature of cosmetic skin care services, including non-surgical treatment of fine lines and wrinkles; beauty therapy treatment services, namely, non-invasive cosmetic therapies for the face and body; beauty therapy treatment services, namely cosmetic skincare treatment services in the nature of providing an injectable dermal filler; skin treatments, namely, the injection of dermal filling agents and neuromuscular blocking agents to reduce the appearance of facial lines and wrinkles; cosmetic skin treatment, namely, injection of dermal filling treatment for cosmetic skin care.
Revendication(s)
- Priority Filing Date: November 22, 2021, Country or Office: EUIPO (EU), Application No. 018605215 in association with the same kind of goods and in association with the same kind of services
Historique des actions
| Action | Date de l'action | Date d'échéance | Commentaires |
|---|---|---|---|
| Produite | 2022-05-20 | Registration | |
| Enregistrement international | 2022-05-20 | 2032-05-20 | |
| Créé | 2022-07-06 | ||
| Formalisée | 2022-07-06 | ||
| Notification de designation - Protocole de Madrid | 2022-07-07 | 2024-01-07 | |
| Changement d'agent | 2022-09-02 | From/De: To/A: 6208 | |
| Changement d'agent | 2022-09-02 | From/De: 6208 To/A: 6208 | |
| Notification d'éventuelle opposition envoyée | 2023-05-08 | ||
| Recherche enregistrée | 2023-10-16 | ||
| Premier rapport de l'examinateur | 2023-10-16 | 2024-04-16 | |
| Refus provisoire total | 2023-10-16 | 2024-04-16 | |
| Changement d'agent | 2024-03-18 | From/De: 6208 To/A: 4 | |
| Approuvée | 2024-11-07 | APPROVED BY PROGRAM EX200M1 | |
| Avis d'approbation envoyé | 2024-11-07 | APPROVED BY PROGRAM EX200M1 | |
| Publiée | 2024-12-04 | Vol.71 Issue 3658 | |
| Notification de commencement de la période d'opposition envoyée | 2024-12-04 | Requested on 2024/12/04 00:30:13 in program jr500m1 | |
| Enregistrement en attente | 2025-02-24 | ||
| Enregistrée | 2025-02-24 | ||
| Déclaration d'octroi de la protection envoyée (suite à un refus provisoire) | 2025-02-24 | ||
| Rectification d'un EI | 2026-03-05 | DP:2026-03-11 Effective date: 2022-05-20 |